- Home
- FMNB vs XOMAO Comparison
FMNB vs XOMAO Comparison
Compare FMNB & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMNB
- XOMAO
- Stock Information
- Founded
- FMNB 1887
- XOMAO N/A
- Country
- FMNB United States
- XOMAO United States
- Employees
- FMNB N/A
- XOMAO 13
- Industry
- FMNB Major Banks
- XOMAO Biotechnology: Pharmaceutical Preparations
- Sector
- FMNB Finance
- XOMAO Health Care
- Exchange
- FMNB Nasdaq
- XOMAO Nasdaq
- Market Cap
- FMNB 579.0M
- XOMAO N/A
- IPO Year
- FMNB N/A
- XOMAO N/A
- Fundamental
- Price
- FMNB $15.34
- XOMAO $25.51
- Analyst Decision
- FMNB Hold
- XOMAO
- Analyst Count
- FMNB 4
- XOMAO 0
- Target Price
- FMNB $15.25
- XOMAO N/A
- AVG Volume (30 Days)
- FMNB 89.1K
- XOMAO N/A
- Earning Date
- FMNB 10-28-2024
- XOMAO N/A
- Dividend Yield
- FMNB 4.49%
- XOMAO N/A
- EPS Growth
- FMNB N/A
- XOMAO N/A
- EPS
- FMNB 1.35
- XOMAO N/A
- Revenue
- FMNB $169,109,000.00
- XOMAO N/A
- Revenue This Year
- FMNB N/A
- XOMAO N/A
- Revenue Next Year
- FMNB $4.60
- XOMAO N/A
- P/E Ratio
- FMNB $11.29
- XOMAO N/A
- Revenue Growth
- FMNB 5.82
- XOMAO N/A
- 52 Week Low
- FMNB $10.38
- XOMAO N/A
- 52 Week High
- FMNB $16.32
- XOMAO N/A
- Technical
- Relative Strength Index (RSI)
- FMNB 60.96
- XOMAO 51.06
- Support Level
- FMNB $14.07
- XOMAO $25.33
- Resistance Level
- FMNB $15.49
- XOMAO $25.64
- Average True Range (ATR)
- FMNB 0.36
- XOMAO 0.12
- MACD
- FMNB 0.09
- XOMAO -0.01
- Stochastic Oscillator
- FMNB 89.44
- XOMAO 34.16
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.
About XOMAO AGNC Investment Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.